News

Vivanza Biosciences Limited will hold a meeting of its Board of Directors on November 3, 2026, at 3:30 P.M. to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, along with a limited review report. The company has closed the trading window for directors, officers, key managerial personnel, and designated persons until 48 hours after the unaudited financial results are declared.

Vivanza Biosciences Limited informed the BSE Limited on October 8, 2026, that the company has not raised any further funds through a public issue, rights issue, or preferential issue, and therefore, the statement of deviation or variation under Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is not applicable.

Vivanza Biosciences Limited informed the BSE Limited that it has received a confirmation certificate from Purva Sharegistry (I) Pvt. Ltd., its Registrar and Share Transfer Agent, for the quarter ended September 30, 2026, under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018.

Vivanza Biosciences Limited will close its trading window for designated persons and their immediate relatives from October 1, 2026, until 48 hours after the declaration of the company’s unaudited financial results for the quarter ending September 30, 2026, in compliance with the Securities & Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.

Vivanza Biosciences Limited will hold a board meeting on August 17, 2026, at its registered office to approve the Director`s Report and Secretarial Audit Report for the financial year 2025-26, convene the 44th Annual General Meeting (AGM), appoint Mr. Chintan K. Patel as Scrutinizer for the e-voting and poll process, fix September 04, 2026, as the cut-off date for the AGM, and seek approval for the adoption of the Memorandum of Association and Articles of Association, proposed borrowings under Section 180(1)(c) of the Companies Act, 2013, and proposed transactions under Section 185 of the Companies Act, 2013, as applicable, along with proposed investments, loans, guarantees and/or securities under Section 186 of the Companies Act, 2013.